C
Carline Vanden Abeele
Researcher at Tibotec
Publications - 3
Citations - 290
Carline Vanden Abeele is an academic researcher from Tibotec. The author has contributed to research in topics: Lopinavir & Lopinavir/ritonavir. The author has an hindex of 3, co-authored 3 publications receiving 283 citations.
Papers
More filters
Journal ArticleDOI
Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis.
Anthony M. Mills,Mark T. Nelson,Dushyantha Jayaweera,Kiat Ruxrungtham,Isabel Cassetti,Pierre Marie Girard,Cassy Workman,Inge Dierynck,Vanitha Sekar,Carline Vanden Abeele,Ludo Lavreys +10 more
TL;DR: Once-daily darunavir/ritonavir was both statistically noninferior and superior in virologic response to LPV/r, with a more favorable gastrointestinal and lipid profile, confirming DRV/ r as an effective, well tolerated, and durable option for antiretroviral-naive patients.
Journal ArticleDOI
In vitro susceptibility and virological outcome to darunavir and lopinavir are independent of HIV type-1 subtype in treatment-naive patients.
Inge Dierynck,Sandra De Meyer,Erkki Lathouwers,Carline Vanden Abeele,Tom Van De Casteele,Sabrina Spinosa-Guzman,Marie-Pierre de Béthune,Gaston Picchio +7 more
TL;DR: In vitro susceptibility to DRV was comparable across HIV-1 subtypes in a broad panel of primary isolates and in recombinant clinical isolates, confirming their broad anti-HIV-1 activity.